Your browser doesn't support javascript.
loading
High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade.
Chua, Kevin L M; Fehlings, Michael; Yeo, Eugenia L L; Nardin, Alessandra; Sumatoh, Hermi; Chu, Pek Lim; Nei, Wen-Long; Ong, Enya H W; Woo, Wai Yee; Low, Kar Perng; Wang, Haitao; Poon, Dennis J J; Liang, Zhong-Guo; Yao, Kai; Huang, Luo; Toh, Chee Keong; Ang, Mei-Kim; Farid, Mohamad; Cheng, Xin Min; Kanesvaran, Ravindran; Dent, Rebecca; Wee, Joseph T S; Lim, Tony K H; Iyer, N Gopalakrishna; Tan, Daniel S W; Soo, Khee Chee; Newell, Evan W; Chua, Melvin L K.
Afiliação
  • Chua KLM; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore.
  • Fehlings M; immunoSCAPE Pte Ltd.
  • Yeo ELL; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Nardin A; immunoSCAPE Pte Ltd.
  • Sumatoh H; immunoSCAPE Pte Ltd.
  • Chu PL; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Nei WL; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore.
  • Ong EHW; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
  • Woo WY; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
  • Low KP; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Wang H; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Poon DJJ; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
  • Liang ZG; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
  • Yao K; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Huang L; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing Cancer Hospital & Institute, Chongqing, People's Republic of China.
  • Toh CK; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Ang MK; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Farid M; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Cheng XM; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Kanesvaran R; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Dent R; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Wee JTS; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore.
  • Lim TKH; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Iyer NG; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore.
  • Tan DSW; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Genome Institute of Singapore, Agency for Science, Technology and Research (A∗S
  • Soo KC; Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore.
  • Newell EW; immunoSCAPE Pte Ltd; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A∗STAR), Singapore; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Chua MLK; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore. Electronic address: Melvin.chua.l.k@singhealth.com.sg.
Int J Radiat Oncol Biol Phys ; 108(1): 70-80, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32544576
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2020 Tipo de documento: Article